CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Generic: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE is FDA application ANDA075502, sponsored by FOUGERA PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly
Temperature Abuse: Complaints received of liquidy texture.
cGMP deviations
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly
Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropio
cGMP deviations